FLOWER-MI and the root of the problem with non-culprit revascularisation

1Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

How do we reduce cardiac death and myocardial infarction by percutaneous coronary intervention (PCI) in coronary heart disease? Although the interventional community continues to grapple with this question in stable angina, the benefits of PCI for non-culprit lesions found at ST-elevation myocardial infarction are established. Is it then wishful thinking that an index developed in stable coronary disease, for identifying lesions capable of causing ischaemia will show an incremental benefit over angiographically guided non-culprit PCI? This is the question posed by the recently published FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction (FLOWER-MI) trial. We examine the trial design and results; ask if there is any relationship between the baseline physiological significance of a non-culprit lesion and vulnerability to future myocardial infarction; and consider if more sophisticated methods can help guide or defer non-culprit revascularisation.

Cite

CITATION STYLE

APA

Li Kam Wa, M. E., de Silva, K., Collet, C., & Perera, D. (2021). FLOWER-MI and the root of the problem with non-culprit revascularisation. Open Heart, 8(2). https://doi.org/10.1136/openhrt-2021-001763

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free